openPR Logo
Press release

Intravenous Immunoglobulin Market Size Estimated to Reach $17.1 Billion by 2026

06-21-2021 10:17 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: IndustryARC

Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market size is estimated to reach $17.1 billion by 2026, growing at a CAGR of 7.5% during the forecast period 2021-2026. Intravenous Immunoglobulins are antibodies that are part of the blood's plasma and are produced naturally by the body's immune system. Intravenous Immunoglobulin (IVIG) is a therapy treatment for patients with various immunodeficiency diseases and bleeding disorders. These are glycoproteins made by the immune system of healthy people for fighting infections. It works in different ways to decrease inflammation in the body. Rise in the adoption of glycoproteins for the treatment of various immunodeficiency diseases, growing demand for immunoglobulin G (IgG) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) and hypogammaglobulinemia, and increasing awareness about the efficiency of intravenous immunoglobulins as a treatment option are the factors that are set to drive the growth of the Intravenous Immunoglobulin Market for the period 2021-2026.

Full Report Link @ https://www.industryarc.com/Research/Intravenous-Immunoglobulin-Market-Research-506919

Intravenous Immunoglobulin Market Segment Analysis-By Product Type

The Intravenous Immunoglobulin Market based on the Product Type can be further segmented into Immunoglobulin G (IgG), Immunoglobulin A (IgA), Immunoglobulin M (IgM), Immunoglobulin E (IgE), and Immunoglobulin D (IgD). The Immunoglobulin G (IgG) segment held the largest share in 2020 owing to its ability to control infection of body tissues and to protect the body from infection by binding many kinds of pathogens, such as viruses and fungi.

The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Immunoglobulin A (IgA) segment is estimated to be the fastest growing segment with a CAGR of 8.3% over the period 2021-2026. This growth is owing to its ability to inhibit bacterial adhesion to epithelial cells and neutralize both bacterial and virus toxins. Immunoglobulin A (IgA) also acts as the first line of defense in the resistance against infection.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=506919
Report Price: $ 5900 (Single User License)

Intravenous Immunoglobulin Market Segment Analysis-By Application

The Intravenous Immunoglobulin Market based on the Application can be further segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Inflammatory Myopathies, Guillain-Barre Syndrome, Specific Antibody Deficiency, and Others. The Hypogammaglobulinemia segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 8.4% over the period 2021-2026. This growth is owing to the factors such as the growing prevalence of hypogammaglobulinemia across the world and the rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia.

The rise in the adoption of intravenous immunoglobulins for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) segment held the second largest share in 2020 owing to the factors such as increase in the prevalence of diabetes mellitus and growing awareness among the consumers about the benefits of minimally invasive and user-friendly procedures for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

Intravenous Immunoglobulin Market Segment Analysis-By Geography

North America held the largest share with 29% of the overall market in 2020. The growth in this segment can be attributed to the factors such as increase in the demand for immunoglobulin G (IgG) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) and rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia.

The rise in the adoption of glycoproteins for the treatment of various immunodeficiency diseases is driving the growth of the Intravenous Immunoglobulin Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing awareness about the efficiency of intravenous immunoglobulins as a treatment option and the rise in the adoption of advanced technologies pertaining to immunoglobulin production.

Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=506919

Intravenous Immunoglobulin Market Drivers

Rise in the Adoption of Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Intravenous Immunoglobulins are increasingly being used for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) owing to its associated benefits such as minimally invasive and user-friendly treatment options. These glycoproteins act as a critical part of the immune response by specifically binding to particular antigens, which is one of the major factors driving the growth of the Intravenous Immunoglobulin Market.

Increase in the Prevalence of Immunodeficiency Diseases and Bleeding Disorders

With an increase in the prevalence of immunodeficiency diseases and bleeding disorders across the world, there is an increase in the awareness among consumers about the efficiency of intravenous immunoglobulins as a treatment option. The key players are also focusing on developed advanced intravenous immunoglobulins for the treatment of various immunodeficiency diseases, which is further propelling the growth of the Intravenous Immunoglobulin Market.

Intravenous Immunoglobulin Market Challenges

High Cost of Intravenous Immunoglobulin Therapy

The government of several nations and other organizations are increasing their initiatives to enhance awareness among people about immunodeficiency diseases and the efficiency of various intravenous immunoglobulins as a treatment option. However, the high cost of Intravenous Immunoglobulin therapy is one of the major factors that is estimated to reduce the growth of the Intravenous Immunoglobulin Market.

Intravenous Immunoglobulin Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Intravenous Immunoglobulin Market. Key companies of this market include Baxter International Inc, Takeda Pharmaceuticals, Bayer Healthcare, AscellaHealth, Kedrion Biopharma, Grifols, Biotest AG, Octapharma AG, LFB group, and Kedrion Biopharma Inc among others.

Partnerships/Product Launches

In November 2020, AscellaHealth has launched its Intravenous Immunoglobulin (IVIG) Medication Therapy to support the aim of the Immune Deficiency Foundation (IDF) and to enhance patient care and cost management approaches.

In June 2020, Grifols has launched its hyperimmune immunoglobulin for the treatment of infections that are applied to healthcare emergencies like the Ebola outbreak and to prevent infections in cases of accidental exposure to infectious agents associated with autoimmune diseases.

In April 2020, Kedrion Biopharma has entered into a partnership with Kamada for the Development, and Distribution of Intravenous Immunoglobulin to make a significant impact for patients in need during the pandemic.

Key Takeaways

Geographically, North America Intravenous Immunoglobulin Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of glycoproteins for the treatment of various immunodeficiency diseases.

The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the Immunoglobulin G (IgG) segment. However, the high cost of intravenous immunoglobulin therapy is one of the major factors that is said to reduce the growth of the Intravenous Immunoglobulin Market.

Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Intravenous Immunoglobulin Market report.

Related Reports :

A. Injectable Drug Delivery Market
https://www.industryarc.com/Report/1255/injectable-drug-delivery-market-analysis.html

B. Monoclonal Antibodies Market
https://www.industryarc.com/Report/16114/monoclonal-antibodies-market.html

For more Lifesciences and Healthcare Market reports @ https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Venkat Reddy
Sales Director
Email: venkat@industryarc.com
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Immunoglobulin Market Size Estimated to Reach $17.1 Billion by 2026 here

News-ID: 2309579 • Views:

More Releases from IndustryARC

Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Forecast Period 2021–2026
Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Foreca …
Professional Diagnostics Market size in 2020 is estimated to be $45 billion, growing at a CAGR of 6.3% during the forecast period 2021-2026. Professional diagnostic is the diagnostic method which are used for faster detection of various diseases such as tuberculosis, cancer, malaria, and others. The main purpose of professional diagnostics is to diagnose or monitor disease in early condition so that treatment can be started so that this diagnostic
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021–2026
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021 …
Body Dryer Market size was valued at $2,978 million in 2020 and is anticipated to reach $5,143 million by the end of 2026 growing at a CAGR of 6.0% during the forecast period 2021-2026. The Body Dryer industry growth rate is attributed to the rising need to reduce medication errors and development of automated systems with improved features and is likely to new opportunities. Body dryers are type of air
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
The India P2P lending Market size is forecast to reach $10.5 billion by 2026, after growing at a CAGR of 21.6% during the forecast period 2021-2026. The Peer to Peer Lending Market growth is attributed to increasing transparency in P2P lending with technologies such as block chain and smart contracts being incorporated into lending platforms. The Indian Government’s enthusiastic promotion of cashless technologies has also managed to restructure the financial
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market is forecast to reach $18.8 billion by 2026, after growing at a CAGR of 38.4% during 2021-2026. With rise in the adoption of IoT technologies and the usage of cloud database for computing in various organizations for different applications is analyzed to boost the Cloud Relational Database Market. Moreover, the cloud databases provide the customers with improved performance, service resilience and so on, thereby enhancing the

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of
Immunoglobulin Market: Grooming Rapidly in Recent Years
Prophecy Market Insights has recently published the Immunoglobulin informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Immunoglobulin market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities
Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are